A Clinical Trial to Investigate the Safety and Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics and Immunogenicity of 2 Dose Regimens of ARGX-117 in Adults With Multifocal Motor Neuropathy (ARDA)
This is a phase 2, randomized, double-blinded, placebo-controlled, parallel-group,
multicenter trial to evaluate the safety and efficacy of 2 dose regimens of ARGX-117 versus
placebo, in participants with MMN previously stabilized with IVIg (intravenous
If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.